Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Catapult Healthcare: Traveling Nurse Agency Recruitment Is on the Rise (Part 1 of 2)

Choosing an agency as a registered nurse can be a daunting task. According to Nurse.org, “Hospitals are trying to cut costs by reducing the number of travel nurses and renegotiating contracts with staffing agencies, but some agencies are still making big promises to travel nurses that can make the whole situation seem like a bait…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Choosing an agency as a registered nurse can be a daunting task. According to Nurse.org, “Hospitals are trying to cut costs by reducing the number of travel nurses and renegotiating contracts with staffing agencies, but some agencies are still making big promises to travel nurses that can make the whole situation seem like a bait and switch.”

Gabrielle Bejarano sat down with Paul Shoe, RN contracted through Catapult Healthcare; Suzanne Raymond, National Recruiter at Catapult Healthcare; and Shannon Kanakaole, Recruiting Operations Manager at Catapult Healthcare, to discuss recruiting best practices and how to work effectively with an agency, in Part 1 of a 2-Part podcast series.

“Communication and transparency are at the forefront of the relationship between the agency and the provider,” said Kanakaole. Nurses need to give recruiters clear direction on what they want and expect from a job. Recruiters need to understand the full range of responsibilities and expectations of the roles they are filling to ensure they are finding the best candidate.

“From the initial call, the first and most important thing is understanding the external factors of where they need to be for their next position or assignment,” said Kanakaole. Recruiters need to be clear on the top three priorities of their candidates. Establishing clarity on must-haves and nice-to-haves ensures recruiters can meet candidates’ needs and create a foundation of trust in the relationship. For nurses, that means knowing their desires and communicating them to a recruiter effectively.

As a nurse coming to an agency, Shoe recommended, “make sure all paperwork is up to date” including everything from licenses, medical records, shots, and vaccines. “The more you have ready to go, the quicker we can get you started after an offer,” said Raymond. It streamlines and simplifies the entire process. Once hired, nurses should continue to have open, honest, and frequent conversations with their recruiters. Maintaining the relationship will help when issues or conflicts need to be addressed.

Listen in to learn more about what to look for when seeking agency representation, how to work successfully with an agency, the role of communications, the changing landscape of the traveling nurse industry, and more. And don’t forget to come back for Part II.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512